Back to today’s briefing

Story perspectives

Xaira Therapeutics Appoints Bo Wang to Lead AI Revolution

4/4/2025

29 3

Summary

Story summary

Bo Wang, Ph.D., has taken the helm as SVP and Head of Biomedical AI at Xaira Therapeutics, where he envisions crafting the first virtual cell through AI technology. This groundbreaking initiative promises to revolutionize drug discovery by accurately predicting cellular responses. With over $1 billion in funding and co-founded by Nobel laureate David Baker, Xaira is poised for transformative advancements in medicine.

1 of 1

Story summary

Bo Wang, Ph.D., has taken the helm as SVP and Head of Biomedical AI at Xaira Therapeutics, where he envisions crafting the first virtual cell through AI technology. This groundbreaking initiative promises to revolutionize drug discovery by accurately predicting cellular responses. With over $1 billion in funding and co-founded by Nobel laureate David Baker, Xaira is poised for transformative advancements in medicine.